Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 407
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03046381 | Tocilizumab in Patients With Schnitzler's Syndrome | ||
| NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | ||
| NCT00483405 | Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer | ||
| NCT03455582 | Cognition Evolution and MRI Markers in PPMS Patients on 2 Years | ||
| NCT02562378 | T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer | ||
| NCT00976456 | Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer | ||
| NCT05396937 | Efficacy and Safety of T+A+RAD in HCC | ||
| NCT01847677 | Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin | ||
| NCT04332822 | A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma | ||
| NCT04400474 | Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study | ||
| NCT01767597 | Application of HBV Rapid Tests as a Tool for Wide-Use Screening | ||
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | ||
| NCT01898117 | Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer | ||
| NCT06068985 | Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade | ||
| NCT01240889 | Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges* | ||
| NCT00284531 | Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients | ||
| NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | ||
| NCT01697267 | Rituximab Vasculitis Maintenance Study | ||
| NCT05733611 | RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC | ||
| NCT06225505 | Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE) | ||
| NCT05919342 | Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF" | ||
| NCT01370772 | Intensified Rituimab Prephase Before FCR in Untreated B-CLL | ||
| NCT01745965 | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. | ||
| NCT04490044 | Under and Over Rehabilitation Study | ||
| NCT00166712 | A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression | ||
| NCT01028092 | mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation | ||
| NCT02708680 | Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In | ||
| NCT00944684 | High Dose Ribavirin in the Treatment of Chronic Hepatitis C | ||
| NCT00316420 | Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer | ||
| NCT03915678 | Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors | ||
| NCT01524679 | Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen | ||
| NCT02383290 | The Implementation of Pharmacogenomics Into Primary Care in British Columbia | ||
| NCT05300282 | Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients | ||
| NCT02636452 | Cardiopulmonary Exercise Testing in Interstitial Lung Disease | ||
| NCT00074438 | Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis | ||
| NCT04888221 | Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement | ||
| NCT01223547 | Study of the Effects of Carbohydrate Counting | ||
| NCT03526601 | Screening Of Adult urBan pOpulation To diAgnose Heart Failure | ||
| NCT00170170 | Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation | ||
| NCT04387994 | Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF. | ||
| NCT04292574 | UK SMA Patient Registry | ||
| NCT00391638 | Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients | ||
| NCT00427375 | Local Excision in Downstaged Rectal Cancer | ||
| NCT01723111 | Impact of Dialysis Modality on Hepcidin and Iron Metabolism | ||
| NCT00208546 | Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer | ||
| NCT05525858 | KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II | ||
| NCT01220596 | Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. | ||
| NCT00203606 | Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C | ||
| NCT03721484 | CINtec PLUS Triage in HPV Primary Screening | ||
| NCT07365930 | NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy |
